Gujarat Kidney and Super Speciality, the mid-sized multispeciality hospitals chain, has filed Red Herring Prospectus with the Registrar of Companies to launch its initial public offering (IPO) next week on December 22. The price band for the offer will be disclosed soon.
The company is raising funds entirely via fresh issue of 2.2 crore equity shares, with no offer-for-sale component, as per the RHP filed on December 12.
The one-day IPO anchor book will be launched December 19, while the offer will remain open for the public subscription till December 24. The company will finalise IPO share allotment by December 26, and its shares will be available for trading on the bourses effective December 30.
Up to 75 percent of the offer has been reserved for qualified institutional buyers, 15 percent for non-institutional investors, and the remainder 10 percent shares for retail investors.
Pragnesh Yashwantsingh Bharpoda-promoter Gujarat Kidney that operates seven multispeciality hospitals and four pharmacies with a total capacity of 490 beds will utilise Rs 77 crore of IPO proceeds for acquisition of Parekhs Hospital at Ahmedabad, and Rs 10.78 crore for acquisition of additional shareholding in subsidiary Harmony Medicare at Bharuch.
Click Here To Read All IPO News
Further, Rs 12.4 crore will be utilised for part-payment of purchase consideration for the already acquired Ashwini Medical Centre, Rs 30 crore for setting up of a new hospital in Vadodara, Rs 6.8 crore for buying robotics equipment, and Rs 1.2 crore for repayment of certain borrowings.
And the remainder funds will be used for inorganic growth and general corporate purposes.
On the financial front, Gujarat Kidney has recorded profit of Rs 5.4 crore on revenue of Rs 15.3 crore for the quarter ended June 2025. Profit for fiscal 2025 increased sharply to Rs 9.5 crore compared to Rs 1.7 crore in previous year. Revenue during the same period surged to Rs 40.2 crore, up from Rs 4.8 crore.
Gujarat Kidney had filed draft papers for IPO in March this year, which subsequentily approved by the SEBI in August.
Nirbhay Capital Services is the sole merchant banker managing the Gujarat Kidney IPO.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
